Read here for an analysis of LifeVantage's (LFVN) stock surge post GLP-1 trial, cautioning on pricing, retention, and ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

During the last year LifeVantage grew its earnings per share (EPS) by 17%. The share price gain of 65% certainly outpaced the ...

26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level ...

LifeVantage Corporation (NASDAQ:LFVN) Q4 2024 Earnings Call Transcript August 28, 2024 LifeVantage Corporation beats earnings expectations. Reported EPS is $0.32, expectations were $0.21.

SALT LAKE CITY, Sept. 10, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

Shares in Lifevantage fell after the company reported lower earnings for the fiscal fourth quarter. Shares were recently down 10.8% at $7.86. The stock is up more than 30% this year. The wellness ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fan-favorite returns for good, bringing refreshing energy and endless summer vibes all year longSALT LAKE CITY, Sept. 04, ...

Recent findings reveal how LifeVantage's two-product system activates GLP-1 production through targeted gene expression and microbiome support*</p ...